Dare Bioscience DARE Cash Flow Statement (2013-2026)

NASDAQ DARE
$0.81 -0.02 (-1.84%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter)
-9.28M-12.79M-9.66M-8.52M0.30M-7.22M-16.30M-8.49M-9.09M-8.50M-5.57M-6.14M-7.58M-4.91M-5.35M-7.00M-5.95M-5.78M-1.64M-3.89M
Depreciation and Depletion (Quarter)
0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M
Share-based Compensation (Quarter)
0.46M-0.46M1.29M0.53M0.54M0.56M-1.04M1.27M-1.27M2.53M0.40M0.79M0.52M0.49M0.74M0.40M0.40M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
0.20M
Cash from Operations (Quarter)
-11.79M1.32M-9.92M-12.34M-8.45M8.60M-5.90M-16.12M-6.59M-7.97M-8.18M-6.81M12.90M-5.92M5.31M-5.50M-5.39M-0.44M1.44M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortization of Deferred Charges (Quarter)
659.000.17M0.09M0.06M0.01M0.00M0.12M-0.05M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.16M0.46M0.48M0.53M
Change in Working Capital
Change in Receivables (Quarter)
0.07M-0.04M
Change in Account Payables (Quarter)
-1.26M0.39M1.50M0.73M-1.72M2.36M-1.45M4.51M-1.55M-1.60M0.01M-1.48M-0.86M0.41M-0.03M-0.12M0.52M-0.62M
Change in Accured Expenses (Quarter)
1.85M-0.42M-0.64M0.40M2.81M-2.21M6.76M-5.41M-1.29M6.70M0.12M0.13M-1.46M1.38M-1.08M0.70M0.81M0.15M
Other Working Capital Changes (Quarter)
-0.08M0.20M0.07M0.56M0.15M-0.15M-1.05M
Investing Activities
Capital Expenditures (Quarter)
0.01M-0.04M-0.09M-0.00M0.15M-0.06M0.04M-0.02M-0.02M0.01M-0.01M0.05M0.52M-0.01M-0.01M0.07M0.34M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Cash from Investing Activities (Quarter)
-0.01M-0.00M-816.00-0.06M-0.00M-0.02M-0.61M-0.01M-0.29M0.28M-0.56M-0.16M0.15M-0.17M-0.21M
Financing Activities
Other financing activities (Quarter)
-0.12M4.72M
Cash from Financing Activities (Quarter)
13.25M35.22M16.00M1.34M0.00M-1.001.30M0.45M8.58M5.31M0.01M0.12M0.44M-0.21M0.25M-0.04M18.65M0.42M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
10.70M36.20M9.30M
Additional items
Exchange Rate Effect (Quarter)
-0.01M-0.06M0.02M-0.01M-0.14M-0.23M0.18M-0.02M-0.03M-0.02M0.06M-0.04M0.01M0.02M-0.07M0.01M0.01M0.01M-0.03M
Change in Cash (Quarter)
1.45M36.46M6.10M-12.36M-7.25M8.32M-5.72M-14.84M-6.17M0.57M-3.42M-6.85M12.75M-5.18M4.47M-5.37M-5.29M18.04M1.64M
Free Cash Flow (Quarter)
-11.79M1.31M-9.88M-12.26M-8.44M8.45M-5.83M-16.12M-6.63M-7.95M-8.16M-6.82M12.91M-5.97M4.78M-5.49M-5.37M-0.51M1.10M
Net Cash Flow (Quarter)
1.46M36.52M6.09M-12.35M-7.11M8.55M-5.90M-14.82M-6.13M0.58M-3.48M-6.81M12.73M-5.21M4.53M-5.41M-5.28M18.03M1.66M